Skip to main content
Fig. 2 | Renal Replacement Therapy

Fig. 2

From: Long-term treatment of evocalcet in hemodialysis patients with secondary hyperparathyroidism: a five-year prospective cohort study in 147 Japanese patients

Fig. 2

Serum i-PTH levels before and after switching from cinacalcet to evocalcet. Purple columns represent values under cinacalcet treatment, while blue ones represent values under evocalcet treatment. No statistically significant differences were observed at any time point compared with the BL values. i-PTH intact parathyroid hormone, BL baseline, × mean values

Back to article page